Fusion proteins and methods for treating HIV infection and AIDS related symptoms
AssigneeTianjin Xiji Biotechnology Co., Ltd.
InventorsPingfan Rao, Shutao Liu
Life of this patent
Estimating the term…
Abstract
The present invention discloses pharmaceutical compositions and methods for using a fusion protein comprising a superoxide dismutase and a transit peptide. The present invention also discloses pharmaceutical compositions and methods for using the fusion protein in combination with other antiretroviral agents for treating patients with AIDS or HTV infection.
Claims8
A method for treating or inhibiting a Human Immunodeficiency Virus (HIV) infection, or treating or inhibiting Acquired Human Immunodeficiency Syndrome (AIDS) in a human patient, said method comprising administering to the human patient a therapeutically effective amount of a fusion protein or a pharmaceutical composition comprising said fusion protein, wherein said fusion protein comprises a superoxide dismutase (SOD) and a transit peptide, and wherein said fusion protein is the fusion protein of SEQ ID NO:
- 1.
Dependencies are inferred from the claim text.